These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 25342923)

  • 1. Optimal management of hereditary hemorrhagic telangiectasia.
    Garg N; Khunger M; Gupta A; Kumar N
    J Blood Med; 2014; 5():191-206. PubMed ID: 25342923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
    Brinjikji W; Iyer VN; Wood CP; Lanzino G
    J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary hemorrhagic telangiectasia.
    Chung MG
    Handb Clin Neurol; 2015; 132():185-97. PubMed ID: 26564080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital Clubbing in Hereditary Hemorrhagic Telangiectasia/Juvenile Polyposis Syndrome.
    Mrzljak A; Popić J; Ožanić Bulić S
    Acta Dermatovenerol Croat; 2021 Apr; 291(1):56-57. PubMed ID: 34477067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.
    Soysal N; Eyries M; Verlhac S; Escabasse V; Remus N; Tamalet A; Rioux JY; Franchi-Abella S; Vasile M; Robert S; Delestrain C; Hau I; Ducou-Le Pointe H; Soubrier F; Carette MF; Epaud R
    Pediatr Pulmonol; 2017 May; 52(5):642-649. PubMed ID: 28165669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rare Case of Hereditary Hemorrhagic Telangiectasia: A Case Report.
    Khan AR; Waqar S; Wazir MH; Arif A
    Cureus; 2022 Apr; 14(4):e24517. PubMed ID: 35651452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): clinical manifestations and multidisciplinary management].
    Frigerio C; Aebischer N; Baud D; Bonafe L; Fellmanne F; Ikonomidis C; Mazzolai L; Michel P; Nichita C; Qanadli SD; Lazor R
    Rev Med Suisse; 2016 May; 12(517):896-901. PubMed ID: 27323484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bevacizumab: a new success in hereditary hemorrhagic telangiectasia].
    Bennesser Alaoui H; Lehraiki M; Hamaz S; El Attar N; Fakhreddine N; Serraj K
    Rev Med Interne; 2015 Sep; 36(9):623-5. PubMed ID: 25595875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osler-Weber-Rendu--a life-threatening disease in adults and children].
    Mei-Zahav M
    Harefuah; 2003 Dec; 142(12):852-6, 876. PubMed ID: 14702755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.
    Sadick H; Sadick M; Götte K; Naim R; Riedel F; Bran G; Hörmann K
    Wien Klin Wochenschr; 2006 Mar; 118(3-4):72-80. PubMed ID: 16703249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.
    Lesca G; Olivieri C; Burnichon N; Pagella F; Carette MF; Gilbert-Dussardier B; Goizet C; Roume J; Rabilloud M; Saurin JC; Cottin V; Honnorat J; Coulet F; Giraud S; Calender A; Danesino C; Buscarini E; Plauchu H;
    Genet Med; 2007 Jan; 9(1):14-22. PubMed ID: 17224686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rendu-Osler-Weber disease: a gastroenterologist's perspective.
    Tortora A; Riccioni ME; Gaetani E; Ojetti V; Holleran G; Gasbarrini A
    Orphanet J Rare Dis; 2019 Jun; 14(1):130. PubMed ID: 31174568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary hemorrhagic teleangiectasia (Rendu-Osler-Weber disease).
    Sabbà C; Pasculli G; Cirulli A; Gallitelli M; Virgilio G; Resta F; Guastamacchia E; Palasciano G
    Minerva Cardioangiol; 2002 Jun; 50(3):221-38. PubMed ID: 12107402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
    Gamboa NT; Joyce EJ; Eli I; Park MS; Taussky P; Schmidt RH; McDonald J; Whitehead KJ; Kalani MYS
    J Clin Neurosci; 2018 May; 51():22-28. PubMed ID: 29483005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician.
    Giordano P; Nigro A; Lenato GM; Guanti G; Suppressa P; Lastella P; DE Mattia D; Sabbà C
    J Thromb Haemost; 2006 Jun; 4(6):1237-45. PubMed ID: 16706966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers.
    Sabbà C; Pasculli G; Lenato GM; Suppressa P; Lastella P; Memeo M; Dicuonzo F; Guant G
    J Thromb Haemost; 2007 Jun; 5(6):1149-57. PubMed ID: 17388964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment.
    Haitjema T; Westermann CJ; Overtoom TT; Timmer R; Disch F; Mauser H; Lammers JW
    Arch Intern Med; 1996 Apr; 156(7):714-9. PubMed ID: 8615703
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.